albendazole sulfoxide has been researched along with Alveolar Echinococcosis, Hepatic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desnica, B; Runje, M; Skuhala, T; Trkulja, V; Vukelic, D | 1 |
| Adas, G; Arikan, S; Karatepe, O; Kemik, O; Oner, A; Sahip, N | 1 |
| Capan, M; Jäger, W; Keltner, S; Ramharter, M; Thalhammer, F; Winkler, S; Zeitlinger, M | 1 |
| Fonseca, F; Mansilla, JA; Manterola, C | 1 |
| Coulaud, JP; Cremieux, AC; Delaitre, B; Giovanangeli, MD; Hay, JM; Meulemans, A; Saimot, AG | 1 |
| Amanvermez, R; Baris, S; Birinci, A; Erzurumlu, K; Hokelek, M; Sahin, M; Tac, K | 1 |
| Asil, M; Deger, BA; Deger, E; Hokelek, M; Pakdemirli, E; Tutar, E | 1 |
| Cotting, J; Reichen, J; Steiger, U | 1 |
1 trial(s) available for albendazole sulfoxide and Alveolar Echinococcosis, Hepatic
| Article | Year |
|---|---|
Preoperative albendazole and scolices viability in patients with hepatic echinococcosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Drug Administration Schedule; Echinococcosis, Hepatic; Echinococcus; Female; Humans; Male; Middle Aged; Premedication; Treatment Failure | 2005 |
7 other study(ies) available for albendazole sulfoxide and Alveolar Echinococcosis, Hepatic
| Article | Year |
|---|---|
Albendazolesulphoxide concentrations in plasma and hydatid cyst and prediction of parasitological and clinical outcomes in patients with liver hydatidosis caused by Echinococcus granulosus.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Biological Availability; Child; Echinococcosis, Hepatic; Echinococcus granulosus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Young Adult | 2014 |
Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study).
Topics: Albendazole; Animals; Anthelmintics; Echinococcosis, Hepatic; Echinococcus granulosus; Humans; In Vitro Techniques; Solutions | 2009 |
Intra-cystic drug concentration of albendazole sulphoxide in patients with Echinococcus granulosus cysts.
Topics: Adult; Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Echinococcus granulosus; Humans; Middle Aged | 2009 |
Albendazole as a potential treatment for human hydatidosis.
Topics: Administration, Oral; Adult; Albendazole; Anthelmintics; Antibodies; Benzimidazoles; Child; Echinococcosis; Echinococcosis, Hepatic; Echinococcus; Female; Humans; Male; Middle Aged; Preoperative Care | 1983 |
Effect of albendazole sulfoxide solution on the scolices and the hepatobiliary system.
Topics: Alanine Transaminase; Albendazole; Alkaline Phosphatase; Animals; Anticestodal Agents; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Cholangitis, Sclerosing; Echinococcosis, Hepatic; Echinococcus; gamma-Glutamyltransferase; Humans; In Vitro Techniques; Liver; Rabbits; Sheep; Time Factors | 1998 |
A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration.
Topics: Albendazole; Animals; Anticestodal Agents; Cysts; Echinococcosis, Hepatic; Injections, Intralesional; Liver; Sheep; Suction; Ultrasonography | 2000 |
Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance.
Topics: Adult; Aged; Albendazole; Aminopyrine; Breath Tests; Drug Tolerance; Echinococcosis, Hepatic; Echinococcosis, Pulmonary; Female; Humans; Liver; Liver Function Tests; Male; Microsomes; Microsomes, Liver; Middle Aged; Neutropenia; Prospective Studies | 1990 |